follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Actavis acquiring Warner Chilcott in all-stock deal

By

Back to Top Comments Email Print

Latest News

advertisement

Parsippany-based Actavis Inc. announced today it will acquire Warner Chilcott PLC in a $5 billion stock swap that’s expected to create a specialty pharmaceuticals company with about $11 million in annual revenue.

Actavis said it will swap 0.16 of a share for each Chilcott share, valuing the Chilcott shares at about $20.08 each. The deal is expected to close by the end of the year.

The new company, Actavis PLC, will be led by the current Actavis leadership team, the company said.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top